Fundamental Analysis
72 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +252.8% | +409.9% | 3 / 3 | +51.9% | -2.35 pp | +0.40 pp | +4.5% | 1.32 | 13.67 | 382 | +51,9% | 2,7 | +252,8% | 13.67 | 17.40 | −21,5% |
| Pts | 12 | 12 | 12 | 12 | 4 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 7.900 (close price on 2026-10-13)EPS (TTM): 578,0
Financial charts
1.Revenue & growth
VND bn382Q3/26
1.Revenue & growth
VND bn382Q3/26
2.Profit & growth
VND bn2,67Q3/26
3.Profit mix (Penman)
VND bn12,4Q3/26
4.Margins & cost structure
%7.9%Q3/26
5.Returns & cash cycle
% · days3.6%Q3/26
6.Earnings quality & cash
VND bn16,9Q3/26
7.Asset structure
VND bn1.187Q3/26
8.Funding & debt health
VND bn · times1.187Q3/26
9.Revenue backlog
VND bn23,4Q3/26
10.Valuation
times · %13,6×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %166Q3/26
Adjusted EPS growth, latest quarter
253%
Average adjusted EPS growth, 3 quarters
420%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q3/26